Kallikrein 13 anticorps
-
- Antigène Voir toutes Kallikrein 13 (KLK13) Anticorps
- Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Kallikrein 13 est non-conjugé
-
Application
- Western Blotting (WB)
- Purification
- Affinity purification
- Immunogène
- Recombinant protein of human KLK13
- Isotype
- IgG
- Top Product
- Discover our top product KLK13 Anticorps primaire
-
-
- Indications d'application
- WB 1:500 - 1:2000
- Commentaires
-
Expressed in prostate, breast, testis and salivary gland
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20C. Avoid freeze / thaw cycles.
-
- Antigène
- Kallikrein 13 (KLK13) (Kallikrein-Related Peptidase 13 (KLK13))
- Autre désignation
- KLK13 (KLK13 Produits)
- Synonymes
- anticorps KLK-L4, anticorps KLKL4, anticorps Egfbp-2, anticorps mGk-13, anticorps kallikrein related peptidase 13, anticorps kallikrein related-peptidase 13, anticorps KLK13, anticorps Klk13
- Sujet
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. An additional transcript variant has been identified, but its full length sequence has not been determined.
- Poids moléculaire
- 30.57 kDa
- ID gène
- 26085
- UniProt
- Q9UKR3
- Pathways
- Système du Complément
-